644 related articles for article (PubMed ID: 33055250)
1. High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing.
Huang W; Soeung V; Boragine DM; Hu L; Prasad BVV; Estes MK; Atmar RL; Palzkill T
J Virol; 2020 Dec; 95(1):. PubMed ID: 33055250
[TBL] [Abstract][Full Text] [Related]
2. Identification of human single-chain antibodies with broad reactivity for noroviruses.
Huang W; Samanta M; Crawford SE; Estes MK; Neill FH; Atmar RL; Palzkill T
Protein Eng Des Sel; 2014 Oct; 27(10):339-49. PubMed ID: 24946948
[TBL] [Abstract][Full Text] [Related]
3. Use of a gene-targeted phage display random epitope library to map an antigenic determinant on the bluetongue virus outer capsid protein VP5.
Wang LF; Du Plessis DH; White JR; Hyatt AD; Eaton BT
J Immunol Methods; 1995 Jan; 178(1):1-12. PubMed ID: 7530266
[TBL] [Abstract][Full Text] [Related]
4. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
Malm M; Tamminen K; Vesikari T; Blazevic V
Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
[TBL] [Abstract][Full Text] [Related]
5. Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.
Garaicoechea L; Aguilar A; Parra GI; Bok M; Sosnovtsev SV; Canziani G; Green KY; Bok K; Parreño V
PLoS One; 2015; 10(8):e0133665. PubMed ID: 26267898
[TBL] [Abstract][Full Text] [Related]
6. Identification of a norovirus GII-specific antigenic epitope.
Liu J; Wang Z; Ma J; Ji S; Huo Y
Arch Virol; 2024 May; 169(6):131. PubMed ID: 38819530
[TBL] [Abstract][Full Text] [Related]
7. A single-amino-acid substitution in the P2 domain of VP1 of murine norovirus is sufficient for escape from antibody neutralization.
Lochridge VP; Hardy ME
J Virol; 2007 Nov; 81(22):12316-22. PubMed ID: 17804495
[TBL] [Abstract][Full Text] [Related]
8. Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response.
Su L; Huang W; Neill FH; Estes MK; Atmar RL; Palzkill T
NPJ Vaccines; 2023 Jun; 8(1):87. PubMed ID: 37280322
[TBL] [Abstract][Full Text] [Related]
9. Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.
Lindesmith LC; Donaldson EF; Beltramello M; Pintus S; Corti D; Swanstrom J; Debbink K; Jones TA; Lanzavecchia A; Baric RS
J Virol; 2014 Aug; 88(16):8826-42. PubMed ID: 24872579
[TBL] [Abstract][Full Text] [Related]
10. The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics.
van Loben Sels JM; Green KY
Viruses; 2019 May; 11(5):. PubMed ID: 31083353
[TBL] [Abstract][Full Text] [Related]
11. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
[TBL] [Abstract][Full Text] [Related]
12. GII.4 Human Norovirus: Surveying the Antigenic Landscape.
Mallory ML; Lindesmith LC; Graham RL; Baric RS
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791623
[TBL] [Abstract][Full Text] [Related]
13. Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.
Opperman PA; Rotherham LS; Esterhuysen J; Charleston B; Juleff N; Capozzo AV; Theron J; Maree FF
J Virol; 2014 Aug; 88(15):8307-18. PubMed ID: 24829347
[TBL] [Abstract][Full Text] [Related]
14. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
Debbink K; Donaldson EF; Lindesmith LC; Baric RS
J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
[TBL] [Abstract][Full Text] [Related]
15. Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.
Yi Y; Wang S; Wang X; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696487
[TBL] [Abstract][Full Text] [Related]
16. Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions.
Lochridge VP; Jutila KL; Graff JW; Hardy ME
J Gen Virol; 2005 Oct; 86(Pt 10):2799-2806. PubMed ID: 16186235
[TBL] [Abstract][Full Text] [Related]
17. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.
Crawford SE; Ajami N; Parker TD; Kitamoto N; Natori K; Takeda N; Tanaka T; Kou B; Atmar RL; Estes MK
Clin Vaccine Immunol; 2015 Feb; 22(2):168-77. PubMed ID: 25428246
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
[TBL] [Abstract][Full Text] [Related]
19. Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries.
Bentley L; Fehrsen J; Jordaan F; Huismans H; du Plessis DH
J Gen Virol; 2000 Apr; 81(Pt 4):993-1000. PubMed ID: 10725425
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
